Table of Contents May 21, 2019; Volume Issue supplement 1

  1. Abasov, Bahadur

    1. Correlation between 18F-FDG PET/CT standardized uptake value with prognostic factors and gene expression profiles in breast cancer: Single center study from Azerbaijan
      Fuad Novruzov, Jamil Aliyev, Sevinc Rehimzade, Sara Mahmudlu, Elmira Jumazade, Elcin Mansurov, Leylakhanim Melikova, Narmin Talibova, Bahadur Abasov, Leyla Mehmetbeyli and Elnur Mehdi
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1234;

  2. Abbaspour, Farzad

    1. Relationship between tumor markers, Ca 15-3 and Ca 125, levels and Sodium-18 Fluoride Positron Emission Tomography Scan in breast cancer bone metastasis
      Farzad Abbaspour, Farzad Kasraei, Peter G Maliha, Nada Almanier, Ahmed Alzahrani, Vilma Derbekyan, Anthony Ciarallo, Robert Lisbona, Javier Novales diaz, Gad Salomon Abikhzar and Marc Hickeson
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1232;

  3. Abbaszadeh, Shiva

    1. Penalized maximum-likelihood image reconstruction for a two-panel PET scanner with image-based resolution modeling.
      Hengquan Zhang and Shiva Abbaszadeh
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 455;
    2. Sub-scanner characterizing for a dedicated head-and-neck cancer PET
      Mohan Li and Shiva Abbaszadeh
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1389;
    3. Towards non-invasive estimate of blood-plasma time activity curve for dynamic PET
      Gregory Romanchek, Brett Yockey and Shiva Abbaszadeh
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 142;

  4. Abbott, Amanda

    1. Report on the PET/CT image-based radiation dosimetry of 18FDHT in women, an imaging agent with new applications for evaluation of androgen receptor status in patients with metastatic breast cancer.
      Keisha McCall, Amanda Abbott, Jiani Hu, Su-Chun Cheng, Sasha Kravets, Shipra Dubey, Diane Young, Mayzie Johnston, Annick D. Van Den Abbeele, Beth Overmoyer and Heather Jacene
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1630;
    2. Imaging Androgen Receptors in Breast Cancer with 18F-fluoro-5α-dihydrotestosterone-PET: A Pilot Study
      Heather Jacene, Jiani Hu, Sasha Kravets, Su-Chun Cheng, Amanda Abbott, SHipra Dubey, Keisha McCall, Diane Young, Mayzie Johnston, Annick D. Van Den Abbeele and Beth Overmoyer
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 595;

  5. Abbruzzese, Bonnie

    1. A Phase I/Phase II Study of Intravenously (IV) Administered Tc 99m Tilmanocept (TCT) to Determine Safety, Tolerability, Optimal Clinical Dose Selection, and Imaging Timepoint in Patients Clinically Diagnosed with Rheumatoid Arthritis (RA)
      Arash Kardan, Allison Kissling, Carley Hartings, Rachael Hershey, Michael Blue, David Ralph, Michael Rosol, Ayah Hussein, Katherine Repp, Lori Christman, Maria Corsi, Ron Korn, Frederick Cope and Bonnie Abbruzzese
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 89;

  6. Abdelsalam, Mohamed

    1. Survival outcomes for transarterial radioembolization with Y-90 glass microspheres in hepatocellular carcinoma patients: a single-institution experience
      Ajalaya Teyateeti, Armeen Mahvash, James Long, Mohamed Abdelsalam, Rony Avritscher, Beth Chasen, Ahmed Kaseb, Joshua Kuban, Bruno Odisio, Ravi Murthy, Achiraya Teyateeti, Homer Macapinlac and Srinivas Kappadath
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 430;
    2. Characterization of uptake and absorbed doses to tumor and normal liver between 99mTc-MAA and 90Y-microspheres in 90Y-radioembolization
      Srinivas Kappadath, Ahmed Kaseb, Mohamed Abdelsalam and Armeen Mahvash
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1633;

  7. Abdullaeva, Sabrina

    1. Examining Ultratrace Iobenguage I-131 for use in Patients with Malignant Pheochromocytoma/Paraganglioma or Metastatic Carcinoid
      Sabrina Abdullaeva, Crystal Botkin, Sarah Frye, Razi Muzaffar and Medhat Osman
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 2046;

  8. Abdulrahman, Aseri

    1. FDG-PET/CTfor assessment of temporomandibular joint metabolic activity in rheumatoid arthritis patientsand healthy subjects
      Aseri Abdulrahman, Abdullah Al-zaghal, Yucheng Chang, Joshua Baker, Thomas Werner, Jonathon Korostoff, Poul Flemming Hoilund-Carlsen and Abass Alavi
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1206;

  9. Abe, Koichiro

    1. Clinical significance of papillary muscle ischemia in transient myocardial ischemic dilatation and dysfunction: Analysis by image fusion of CT angiography and time of flight13N PET.
      Kenji Fukushima, Michinobu Nagao, Risako Nakao, Yoko Kaimoto, Tomohiko Yamane, Ichiei Kuji and Koichiro Abe
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1424;

  10. Abe, Shinji

    1. Evaluation of 223Ra therapy on bone metastases of prostate cancer by 18F-fluoride PET/CT, 18F-FDG PET/CT and bone scintigraphy/SPECT
      Katsuhiko Kato, Tetsuro Odagawa, Naotoshi Fujita, Yoshinori Tsutsumi, Shinji Abe, Seiichi Yamamoto and Shinji Naganawa
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 534;
    2. Optimal threshold for detection of the lesion site in 18F-FDG PET studies on cardiac sarcoidosis
      Rina Murayama, Chinatsu Hasegawa, Tetsuro Odagawa, Shinji Abe and Katsuhiko Kato
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 3014;
    3. Development of a radon and radon daughter monitoring systems for detection of Radium-223 daughter radionuclides in air
      Seiichi Yamamoto, Katsuhiko Kato, Naotoshi Fujita, Masato Yamashita, Takuya Nishimoto, Hiroshi Kameyama and Shinji Abe
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1386;
    4. Evaluation of radionuclide therapy for the palliation of bone metastasis pain using 89Sr: Comparison of SUV values of bone metastases measured by 99mTc bone SPECT, 18F-fluoride PET/CT, and 18F-FDG PET/CT
      Chinatsu Hasegawa, Tomohiro Tada, Rina Murayama, Tetsuro Odagawa, Shinji Abe and Katsuhiko Kato
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 2029;
    5. Comparative examination of the cerebellum and pons as reference regions for quantitative evaluation in PET imaging for Alzheimer's disease using11C-Pittsburgh Compound-B
      Tomohiro Tada, Chinatsu Hasegawa, Tetsuro Odagawa, Shinji Abe and Katsuhiko Kato
      Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 3012;
« Previous (Pages : 1 2 3 4 5 6 ... 537) Next »
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 21, 2019
Sign up for alerts